ENaC contributes to macrophage dysfunction in cystic fibrosis

Authors:

Abstract
New research reveals that epithelial sodium channel (ENaC) overexpression in cystic fibrosis (CF) immune cells impairs macrophage function. Inhibiting ENaC increases cystic fibrosis transmembrane conductance regulator (CFTR) expression, normalizes reactive oxygen species production, improves autophagy, and reduces proinflammatory cytokine production. This suggests that ENaC modulation could be a novel therapeutic target for CF infection control, either alone or with CFTR modulators, offering new hope for patients not eligible for current treatments.
All Related Versions
Funding Information
  • Cystic Fibrosis Foundation (KOPP20I0)
  • HHS | National Institutes of Health (R01 HL158747)
  • HHS | National Institutes of Health (R01 HL148171)
  • Cystic Fibrosis Foundation (MCCOY19RO)
  • HHS | National Institutes of Health (P30-DK125013)

This publication has 32 references indexed in Scilit: